Link Details
- Metabolite
- HMDB0000067 (Cholesterol)
- DrugBank ID
- DB01393
- Drug Name
- Bezafibrate
- Effect
- Decrease
- Biospecimen
- Blood
- P-value
- Not Available
- Beta Estimator
- Not Available
- Percent Change
- Not Available
- Pearson Correlation Coefficient
- Not Available
- Comments
- Not Available
- Hidalgo L, Zambrana JL, Blanco-Molina A, Lopez-Granados A, Concha M, Casares J, Jimenez-Perez J, Lopez-Miranda J, Perez-Jimenez F: Lovastatin versus bezafibrate for hyperlipemia treatment after heart transplantation. J Heart Lung Transplant. 1995 May-Jun;14(3):461-7. [PubMed:7654731 ]
- Zimetbaum P, Frishman WH, Kahn S: Effects of gemfibrozil and other fibric acid derivatives on blood lipids and lipoproteins. J Clin Pharmacol. 1991 Jan;31(1):25-37. [PubMed:2045526 ]
- Kobayashi J, Takahashi K, Tashiro J, Shirai K, Saito Y, Yoshida S, Hashimoto H, Fukamachi I, Niihara K, Sasaki N: Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia. Arzneimittelforschung. 1994 Feb;44(2):145-8. [PubMed:8147947 ]
- Nakandakare E, Garcia RC, Rocha JC, Sperotto G, Oliveira HC, Quintao EC: Effects of simvastatin, bezafibrate and gemfibrozil on the quantity and composition of plasma lipoproteins. Atherosclerosis. 1990 Dec;85(2-3):211-7. [PubMed:2102085 ]
- Rustemeijer C, Schouten JA, Voerman HJ, Hensgens HE, Donker AJ, Heine RJ: Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with type 2 diabetes mellitus. Diabetes Metab Res Rev. 2000 Mar-Apr;16(2):82-7. [PubMed:10751747 ]
- Stewart MW, Dyer RG, Alberti KG, Laker MF: The effects of lipid lowering drugs on metabolic control and lipoprotein composition in type 2 diabetic patients with mild hyperlipidaemia. Diabet Med. 1995 Mar;12(3):250-7. [PubMed:7758262 ]
- Klosiewicz-Latoszek L, Szostak WB: Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia. Eur J Clin Pharmacol. 1991;40(1):33-41. [PubMed:2060543 ]
- McCullough PA, Ahmed AB, Zughaib MT, Glanz ED, Di Loreto MJ: Treatment of hypertriglyceridemia with fibric acid derivatives: impact on lipid subfractions and translation into a reduction in cardiovascular events. Rev Cardiovasc Med. 2011;12(4):173-85. doi: 10.3909/ricm0619. [PubMed:22249508 ]